A detailed history of Nicholas Investment Partners, LP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 29,625 shares of IDYA stock, worth $734,403. This represents 0.1% of its overall portfolio holdings.

Number of Shares
29,625
Previous 71,036 58.3%
Holding current value
$734,403
Previous $2.49 Million 62.39%
% of portfolio
0.1%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$30.37 - $43.05 $1.26 Million - $1.78 Million
-41,411 Reduced 58.3%
29,625 $938,000
Q2 2024

Aug 07, 2024

SELL
$34.37 - $43.46 $2.91 Million - $3.68 Million
-84,784 Reduced 54.41%
71,036 $2.49 Million
Q1 2024

May 13, 2024

BUY
$34.2 - $47.13 $1.56 Million - $2.14 Million
45,469 Added 41.2%
155,820 $6.84 Million
Q4 2023

Feb 07, 2024

BUY
$24.59 - $35.83 $2.71 Million - $3.95 Million
110,351 New
110,351 $3.93 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.19B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.